Polyelectrolyte Microcapsules—A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release
Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissue...
Saved in:
| Published in | International journal of molecular sciences Vol. 24; no. 4; p. 3348 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
08.02.2023
MDPI |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO3 microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO3 microspherulites and polyelectrolyte microcapsules CaCO3(PAH/PSS)3, but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS)3. Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25–30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases |
|---|---|
| AbstractList | Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO[sub.3] microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO[sub.3] microspherulites and polyelectrolyte microcapsules CaCO[sub.3](PAH/PSS)[sub.3], but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS)[sub.3]. Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25-30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO3 microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO3 microspherulites and polyelectrolyte microcapsules CaCO3(PAH/PSS)3, but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS)3. Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25–30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO3 microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO3 microspherulites and polyelectrolyte microcapsules CaCO3(PAH/PSS)3, but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS)3. Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25-30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases.Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO3 microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO3 microspherulites and polyelectrolyte microcapsules CaCO3(PAH/PSS)3, but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS)3. Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25-30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases. Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO microspherulites and polyelectrolyte microcapsules CaCO (PAH/PSS) , but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS) . Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25-30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases. Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm. Amiodarone is one of these highly effective preparations, but, at the same time, it has significant toxicity and nonspecific accumulation in tissues. The drug delivery system based on polyelectrolyte microcapsules is one of the solutions. For this purpose, we compared different encapsulation methods of amiodaron: monoammonium salt of glycyrrhizic acid (Am:MASGA) complex (molar ratio 1:8). The concentration of amiodarone was determined by spectrophotometric methods at 251 nm. It has been shown that the co-precipitation method allows capturing 8% of Am:MASGA by CaCO 3 microspherulites, which is not sufficient for the long-acting drug. The adsorption method allows encapsulating more than 30% of Am:MASGA into CaCO 3 microspherulites and polyelectrolyte microcapsules CaCO 3 (PAH/PSS) 3 , but, at the same time, an insignificant amount of substance is released into the incubation medium. The development of delivery and long-acting drug system based on such methods are not inexpedient. The most appropriate encapsulation method of Am:MASGA is the adsorption method into polyelectrolyte microcapsules with complex interpolyelectrolyte structure (PAH/PSS) 3 . Such a type of PMC adsorbed about 50% of the initial amount of the substance and 25–30% of Am:MASGA was released into the medium after 115 h of incubation. The adsorption of Am:MASGA by polyelectrolyte microcapsules has electrostatic nature as evidenced by the acceleration of the release by 1.8 times as ionic strength increases |
| Audience | Academic |
| Author | Kim, Aleksandr L. Musin, Egor V. Salikhov, Shavkat I. Tikhonenko, Sergey A. Oshchepkova, Yulia I. Oripova, Munojat J. |
| AuthorAffiliation | 1 Institute of Theoretical and Experimental Biophysics Russian Academy of Science, Institutskaya St., 3, 142290 Puschino, Moscow Region, Russia 2 Institute of Bioorganic Chemistry named after O.Sodikov Academy of Sciences of the Republic of Uzbekistan, M. Ulugbek Str., 83, Tashkent 100125, Uzbekistan |
| AuthorAffiliation_xml | – name: 1 Institute of Theoretical and Experimental Biophysics Russian Academy of Science, Institutskaya St., 3, 142290 Puschino, Moscow Region, Russia – name: 2 Institute of Bioorganic Chemistry named after O.Sodikov Academy of Sciences of the Republic of Uzbekistan, M. Ulugbek Str., 83, Tashkent 100125, Uzbekistan |
| Author_xml | – sequence: 1 givenname: Aleksandr L. orcidid: 0000-0002-8129-9635 surname: Kim fullname: Kim, Aleksandr L. – sequence: 2 givenname: Egor V. orcidid: 0000-0003-4038-2042 surname: Musin fullname: Musin, Egor V. – sequence: 3 givenname: Munojat J. orcidid: 0000-0001-8686-3568 surname: Oripova fullname: Oripova, Munojat J. – sequence: 4 givenname: Yulia I. orcidid: 0000-0002-4619-458X surname: Oshchepkova fullname: Oshchepkova, Yulia I. – sequence: 5 givenname: Shavkat I. surname: Salikhov fullname: Salikhov, Shavkat I. – sequence: 6 givenname: Sergey A. orcidid: 0000-0002-0537-9537 surname: Tikhonenko fullname: Tikhonenko, Sergey A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36834760$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkktvEzEQxy1URB9w44wsceFAitf2ru0LUlSeUhERlLPleGc3jrzrYHuLwokPwSfkk-CoLaRV5cOM7N_8x_M4RgdjGAGhpxU5ZUyRV249JMoJZ4zLB-io4pTOCGnEwZ5_iI5TWhNCGa3VI3TIGsm4aMgR-rkIfgsebI7FyYA_ORuDNZs0eUh_fv2e40UMg0tu7PGFiT1k_Aa8u4S4xV-3KcOAQ4fngwutieVn-IfLK5xXgBchJbd03uXtDikyPow9tPhLyWcSPEYPO-MTPLm2J-jbu7cXZx9m55_ffzybn88sFyrPJBEgmq5mFZdQQ0NtKxuo6q4jhklLJF22tWqFKMYapmpmW8UVbTsimSGWnaDXV7qbaTlAa2HM0Xi9iW4wcauDcfr2y-hWug-XWqmmkZIWgRfXAjF8nyBlXfphwXszQpiSpkISIqTisqDP76DrMMWxlFcooWpOatr8p3rjQbuxCyWv3YnquagrRXlFRaFO76HKaWFwtrS6c-X-VsCz_UL_VXgz7QLQK6CMOKUInbYum-zCrm7ndUX0bqX0_kqVoJd3gm5078X_Akzcz2A |
| CitedBy_id | crossref_primary_10_3390_polym16111521 crossref_primary_10_3390_pharmaceutics16060785 crossref_primary_10_3390_ijms25052652 crossref_primary_10_1016_j_ijbiomac_2024_129742 |
| Cites_doi | 10.1097/MJT.0000000000001035 10.3390/ijms23010006 10.7326/0003-4819-125-4-199608150-00010 10.1016/j.tcm.2018.09.005 10.1016/j.tcm.2020.10.010 10.1021/acs.bioconjchem.8b00882 10.1016/j.cocis.2006.05.001 10.1161/CIR.0000000000000665 10.1021/la036177z 10.1136/bmj.330.7485.238 10.1007/s12265-019-09905-1 10.1038/s41598-021-93565-2 10.1001/jama.1994.03510350050036 10.1016/j.powtec.2018.08.066 10.1007/s002280050388 10.1039/B808262F 10.2147/IJN.S98815 10.1161/01.CIR.72.5.1064 10.1016/S0735-1097(84)80367-8 10.1016/j.phrs.2019.104521 10.1016/S0002-9149(98)00583-9 10.1039/c0jm01231a 10.1134/S0036024406100281 10.1016/S0927-7757(03)00195-X 10.1053/j.jvca.2020.10.060 10.1161/CIRCOUTCOMES.110.958165 10.1161/CIRCEP.118.006408 10.3390/ijms23179917 10.1201/9781420004656 10.1016/0002-8703(81)90140-X 10.1134/S1068162013050087 10.1021/acssuschemeng.9b05128 10.1056/NEJM200104053441407 10.1021/bp0495825 10.1007/s12325-011-0065-6 10.1186/1471-2261-2-5 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
| Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.3390/ijms24043348 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1422-0067 |
| ExternalDocumentID | PMC9966882 A751924127 36834760 10_3390_ijms24043348 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: State Assignment of the Russian Federation grantid: 075-01025-23-00 |
| GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI CGR CUY CVF ECM EIF GROUPED_DOAJ HCIFZ KB. M7P M~E NPM PDBOC PMFND 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c479t-807e76f53148e5e62cd86e15ff0a38c082bd59d77bd5ca3953cd9492df083a0c3 |
| IEDL.DBID | M48 |
| ISSN | 1422-0067 1661-6596 |
| IngestDate | Thu Aug 21 18:37:52 EDT 2025 Mon Jul 21 10:17:24 EDT 2025 Fri Jul 25 20:11:42 EDT 2025 Tue Jun 17 21:06:08 EDT 2025 Tue Jun 10 20:44:48 EDT 2025 Wed Feb 19 02:25:15 EST 2025 Tue Jul 01 02:03:29 EDT 2025 Thu Apr 24 22:59:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | encapsulation drug delivery amiodarone polyelectrolyte microcapsules target delivery |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c479t-807e76f53148e5e62cd86e15ff0a38c082bd59d77bd5ca3953cd9492df083a0c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4038-2042 0000-0002-8129-9635 0000-0002-0537-9537 0000-0001-8686-3568 0000-0002-4619-458X |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms24043348 |
| PMID | 36834760 |
| PQID | 2779540526 |
| PQPubID | 2032341 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9966882 proquest_miscellaneous_2780078948 proquest_journals_2779540526 gale_infotracmisc_A751924127 gale_infotracacademiconefile_A751924127 pubmed_primary_36834760 crossref_citationtrail_10_3390_ijms24043348 crossref_primary_10_3390_ijms24043348 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20230208 |
| PublicationDateYYYYMMDD | 2023-02-08 |
| PublicationDate_xml | – month: 2 year: 2023 text: 20230208 day: 8 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | International journal of molecular sciences |
| PublicationTitleAlternate | Int J Mol Sci |
| PublicationYear | 2023 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Benjamin (ref_5) 1994; 271 Golzari (ref_7) 1996; 125 Kochetkova (ref_30) 2013; 39 Zipes (ref_15) 1984; 3 ref_35 Trohman (ref_18) 2019; 29 Sukhorukov (ref_29) 2007; 52 Feduska (ref_17) 2021; 35 Primeau (ref_21) 1989; 5 Bahrom (ref_37) 2019; 7 Musin (ref_32) 2021; 11 Bockeria (ref_24) 2020; 13 Volodkin (ref_31) 2004; 20 Sukhorukov (ref_28) 2009; 5 Petrov (ref_41) 2008; 21 Kannel (ref_8) 1998; 82 Musin (ref_40) 2022; 23 January (ref_2) 2019; 140 Ahmed (ref_25) 2019; 30 Valembois (ref_16) 2019; 2019 Johnston (ref_27) 2006; 11 Candinas (ref_19) 1998; 53 Iqbal (ref_12) 2005; 330 Won (ref_33) 2010; 20 Alonso (ref_6) 2021; 31 Adams (ref_20) 1985; 72 Antipov (ref_36) 2003; 224 Pathmanathan (ref_22) 2021; 28 Dubrovskii (ref_39) 2006; 80 ref_3 Marcus (ref_14) 1981; 101 Oral (ref_38) 2018; 339 Kim (ref_11) 2011; 4 Garcia (ref_23) 2018; 11 ref_9 Dobrev (ref_13) 2020; 151 Zhuge (ref_26) 2016; 11 Mozaffarian (ref_4) 2015; 131 Kazakova (ref_34) 2007; 52 Amin (ref_10) 2011; 28 Falk (ref_1) 2001; 344 |
| References_xml | – volume: 5 start-page: 98 year: 1989 ident: ref_21 article-title: Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias publication-title: Can. J. Cardiol. – volume: 28 start-page: e165 year: 2021 ident: ref_22 article-title: Amiodarone-Associated Neurotoxicity publication-title: Am. J. Ther. doi: 10.1097/MJT.0000000000001035 – ident: ref_3 doi: 10.3390/ijms23010006 – volume: 125 start-page: 311 year: 1996 ident: ref_7 article-title: Atrial Fibrillation: Restoration and Maintenance of Sinus Rhythm and Indications for Anticoagulation Therapy publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-125-4-199608150-00010 – volume: 29 start-page: 285 year: 2019 ident: ref_18 article-title: Amiodarone and thyroid physiology, pathophysiology, diagnosis and management publication-title: Trends Cardiovasc. Med. doi: 10.1016/j.tcm.2018.09.005 – volume: 31 start-page: 469 year: 2021 ident: ref_6 article-title: Mortality in atrial fibrillation. Is it changing? publication-title: Trends Cardiovasc. Med. doi: 10.1016/j.tcm.2020.10.010 – volume: 30 start-page: 733 year: 2019 ident: ref_25 article-title: A Supramolecular Nanocarrier for Delivery of Amiodarone Anti-Arrhythmic Therapy to the Heart publication-title: Bioconjug. Chem. doi: 10.1021/acs.bioconjchem.8b00882 – volume: 11 start-page: 203 year: 2006 ident: ref_27 article-title: Layer-by-layer engineered capsules and their applications publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/j.cocis.2006.05.001 – volume: 131 start-page: e29 year: 2015 ident: ref_4 article-title: Heart Disease and Stroke Statistics—2015 Update publication-title: Circulation – volume: 140 start-page: e125 year: 2019 ident: ref_2 article-title: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R publication-title: Circulation doi: 10.1161/CIR.0000000000000665 – volume: 20 start-page: 3398 year: 2004 ident: ref_31 article-title: Matrix Polyelectrolyte Microcapsules: New System for Macromolecule Encapsulation publication-title: Langmuir doi: 10.1021/la036177z – volume: 330 start-page: 238 year: 2005 ident: ref_12 article-title: Recent developments in atrial fibrillation publication-title: BMJ doi: 10.1136/bmj.330.7485.238 – volume: 13 start-page: 191 year: 2020 ident: ref_24 article-title: Epicardial Application of Hydrogel with Amiodarone for Prevention of Postoperative Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting publication-title: J. Cardiovasc. Transl. Res. doi: 10.1007/s12265-019-09905-1 – volume: 11 start-page: 14040 year: 2021 ident: ref_32 article-title: New sight at the organization of layers of multilayer polyelectrolyte microcapsules publication-title: Sci. Rep. doi: 10.1038/s41598-021-93565-2 – volume: 271 start-page: 840 year: 1994 ident: ref_5 article-title: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study publication-title: JAMA doi: 10.1001/jama.1994.03510350050036 – volume: 52 start-page: 850 year: 2007 ident: ref_34 article-title: An electron microscopy study of the structure of polyelectrolyte microcapsules containing protein and containing no protein publication-title: Biofizika – volume: 339 start-page: 781 year: 2018 ident: ref_38 article-title: Influence of pH on morphology, size and polymorph of room temperature synthesized calcium carbonate particles publication-title: Powder Technol. doi: 10.1016/j.powtec.2018.08.066 – volume: 53 start-page: 331 year: 1998 ident: ref_19 article-title: Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s002280050388 – volume: 5 start-page: 282 year: 2009 ident: ref_28 article-title: Polyelectrolyte microcapsules for biomedical applications publication-title: Soft Matter doi: 10.1039/B808262F – volume: 11 start-page: 2359 year: 2016 ident: ref_26 article-title: Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S98815 – volume: 72 start-page: 1064 year: 1985 ident: ref_20 article-title: Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy publication-title: Circulation doi: 10.1161/01.CIR.72.5.1064 – volume: 3 start-page: 1059 year: 1984 ident: ref_15 article-title: Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects publication-title: J. Am. Coll. Cardiol. doi: 10.1016/S0735-1097(84)80367-8 – volume: 151 start-page: 104521 year: 2020 ident: ref_13 article-title: The role of amiodarone in contemporary management of complex cardiac arrhythmias publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104521 – volume: 82 start-page: 2N year: 1998 ident: ref_8 article-title: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates 11Reprints are not available publication-title: Am. J. Cardiol. doi: 10.1016/S0002-9149(98)00583-9 – volume: 20 start-page: 7728 year: 2010 ident: ref_33 article-title: Multifunctional calcium carbonate microparticles: Synthesis and biological applications publication-title: J. Mater. Chem. doi: 10.1039/c0jm01231a – volume: 80 start-page: 1703 year: 2006 ident: ref_39 article-title: Influence of the temperature on polyelectrolyte microcapsules: Light scattering and confocal microscopy data publication-title: Russ. J. Phys. Chem. A doi: 10.1134/S0036024406100281 – volume: 224 start-page: 175 year: 2003 ident: ref_36 article-title: Carbonate microparticles for hollow polyelectrolyte capsules fabrication publication-title: Colloids Surf. Physicochem. Eng. Asp. doi: 10.1016/S0927-7757(03)00195-X – volume: 35 start-page: 1485 year: 2021 ident: ref_17 article-title: Acute Amiodarone Pulmonary Toxicity publication-title: J. Cardiothorac. Vasc. Anesth. doi: 10.1053/j.jvca.2020.10.060 – volume: 4 start-page: 313 year: 2011 ident: ref_11 article-title: Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation in the United States publication-title: Circ. Cardiovasc. Qual. Outcomes doi: 10.1161/CIRCOUTCOMES.110.958165 – volume: 11 start-page: e006408 year: 2018 ident: ref_23 article-title: Minimally Invasive Delivery of Hydrogel-Encapsulated Amiodarone to the Epicardium Reduces Atrial Fibrillation publication-title: Circ. Arrhythmia Electrophysiol. doi: 10.1161/CIRCEP.118.006408 – volume: 23 start-page: 9917 year: 2022 ident: ref_40 article-title: A Study of the Buffer Capacity of Polyelectrolyte Microcapsules Depending on Their Concentration and the Number of Layers of the Polyelectrolyte Shell publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23179917 – ident: ref_35 doi: 10.1201/9781420004656 – volume: 101 start-page: 480 year: 1981 ident: ref_14 article-title: Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone publication-title: Am. Heart J. doi: 10.1016/0002-8703(81)90140-X – volume: 52 start-page: 1041 year: 2007 ident: ref_29 article-title: Encapsulation of enzymes in polyelectrolyte nano- and microcapsules in connection with the problem of microdiagnostics publication-title: Biophysics – volume: 39 start-page: 504 year: 2013 ident: ref_30 article-title: Incorporation of proteins into polyelectrolyte microcapsules by coprecipitation and adsorption publication-title: Russ. J. Bioorganic Chem. doi: 10.1134/S1068162013050087 – volume: 7 start-page: 19142 year: 2019 ident: ref_37 article-title: Controllable Synthesis of Calcium Carbonate with Different Geometry: Comprehensive Analysis of Particle Formation, Cellular Uptake, and Biocompatibility publication-title: ACS Sustain. Chem. Eng. doi: 10.1021/acssuschemeng.9b05128 – volume: 344 start-page: 1067 year: 2001 ident: ref_1 article-title: Atrial Fibrillation publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200104053441407 – volume: 21 start-page: 918 year: 2008 ident: ref_41 article-title: Protein-Calcium Carbonate Coprecipitation: A Tool for Protein Encapsulation publication-title: Biotechnol. Prog. doi: 10.1021/bp0495825 – volume: 28 start-page: 907 year: 2011 ident: ref_10 article-title: Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors publication-title: Adv. Ther. doi: 10.1007/s12325-011-0065-6 – volume: 2019 start-page: CD005049 year: 2019 ident: ref_16 article-title: Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation publication-title: Cochrane Database Syst. Rev. – ident: ref_9 doi: 10.1186/1471-2261-2-5 |
| SSID | ssj0023259 |
| Score | 2.3864229 |
| Snippet | Atrial fibrillation is one of the most common cardiac arrhythmias. Pharmacological preparations are used for treatment to control heart rate and rhythm.... |
| SourceID | pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 3348 |
| SubjectTerms | Adsorption Amiodarone Atrial fibrillation Capsules - chemistry Cardiac arrhythmia Drug Delivery Systems Electrical conductivity Ethylenediaminetetraacetic acid Heart Nanoparticles Polyelectrolytes Product introduction |
| SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgCIkL4puUgowE4oCibhx_xCe0ApYKCbRCrdRblNhOWZTG7WZ7CCd-BL-QX8JM4g0bJDjl4EkyytieN9638wh5kWGLdV2JWFioVbmWPC5KAHJSJJVGlUle9Szfz_LohH88FafhwK0NtMrtnthv1NYbPCM_ZEppRBdMvrm4jFE1Cn9dDRIa18mNBDINUrqyxYex4EpZL5aWQA6Cl2s5EN9TKPMPV9_OW4adZVJU_tlJSX9vzDuZacqa3ElDizvkdsCPdD4E_C655pp75OagKNndJ9-Xvu6CtE3dbRz9hIQ7U0AtXLv214-fc7pce4gtZCx63LPA6TtXIzmjo0P3cuorOj9feVusfeMoHtRSQIl06dtApe3QBB5T--bMWfoF3ge58AE5Wbw_fnsUB3mF2HClN9iG2ClZwSLkmRNOMmMz6RJRVbMizQxgg9IKbZWCiylSLVJjNdfMVgDbiplJH5K9Bhx5TKhzheDGcuYQIlZlqR0Y8oIrCIE0LCKvt184N6H3OEpg1DnUIBiPfDceEXk5Wl8MPTf-YfcKg5XjUoSnmSL8owB8wqZW-VwJLC8TpiJyMLGEz2ymw9tw52EJt_mfCReR5-Mw3om0tMb5K7TJEGNp9OXRMDtGj1OZpVzJWUTUZN6MBtjYezrSrL72Db6xBoXKZ___bj0htxjM8Z5Cnh2Qvc36yj0FhLQpn_XL4DdDPhIS priority: 102 providerName: ProQuest |
| Title | Polyelectrolyte Microcapsules—A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36834760 https://www.proquest.com/docview/2779540526 https://www.proquest.com/docview/2780078948 https://pubmed.ncbi.nlm.nih.gov/PMC9966882 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB71ISQuFW8MJVokEAdkSOx9eA8IBWiokFpFVSPlZtm7awhy7ZKkEubEj-AX8kuYsR0r5nWxDzu2Rzuznm_Wn2cAnkRUYl1nwhcWc1WuJfeTFIGcFKNMU5dJntUs31N5POMf5mK-A5tuo-0Erv6a2lE_qdkyf_H1S_UaF_wryjgxZX-5-HyxCqhKTMijXdjHmKSol8EJ774nIGyo26bRhodPL-iGAv_H1b3g9PsreitG9fmTWwFpcgMOWiTJxo3pb8KOK27Btaa3ZHUbvk3LvGqb3OTV2rETot6ZBLPi3K1-fv8xZtNliVbG2MXOaz44e-dyomlUrKljzsqMjS8WpU2WZeEYbdkyxItsWq5aUm1FInibvCw-OsvO8HkYFe_AbHJ0_vbYbxst-IYrvaaCxE7JDJcjj5xwMjA2km4ksmyYhJFBlJBaoa1SeDJJqEVorOY6sBkCuGRowruwV6Ai94E5lwhuLA8cgcUsTbVDQZ5whSaQJvDg-WaGY9NWIadmGHmM2QjZI962hwdPO-nLpvrGP-SekbFichO8m0nafwtQJypvFY-VoERzFCgPDnuSOM2mP7wxd7zxxThQShOwDaQHj7thupIIaoUrr0gmIrSlSZd7jXd0GocyCrmSQw9Uz286ASrx3R8pFp_qUt-UjWIO9OD_Wj-E6wH6eE0mjw5hb728co8QK63TAeyqucJjNHk_gP03R6fTswFFLzGoF8gvK5wYpg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRQguiDeBBYzEigOqtnX8iA8IVSylyz5Uoa60t5DYDhRlk6XpCoUTP4LfwY_ilzCTFw0S3PbUg6fuxDP2zKSfvyHkWYAU6zoRA2GhVuVa8kEUQyInxSjR2GWSJxXK90hOj_m7E3GyQX62d2EQVtmeidVBbXOD78h3mFIaswsmX519GWDXKPx3tW2hUbvFviu_QslWvNzbBftuMzZ5M389HTRdBQaGK71C9l2nZAK-xwMnnGTGBtKNRJIMIz8wEBJjK7RVCj5M5GvhG6u5ZjaBbCUaGh_mvUQucx8iOd5Mn7ztCjyfVc3ZRhDz4GG1rIH2IDjcWXw-LRgy2fjYaWgtBP4dCNYiYR-luRb2JjfI9SZfpePawW6SDZfdIlfqDpblbfJtlqdl00onLVeOHiLAz0RQe6eu-PX9x5jOljn4EkRIOq9Q53TXpQgGKWnNlk7zhI5PF7mNlnnmKL4YppCV0lleNNDdEkVgmjTPPjpL38PvQey9Q44vZOHvks0MFLlPqHOR4MZy5jAlTeJYOxDkEVdgAmmYR160KxyahuscW26kIdQ8aI9w3R4e2e6kz2qOj3_IPUdjhbj1YTYTNTcYQCck0QrHSmA5O2LKI1s9SVhm0x9uzR02R0YR_nFwjzzthvGbCIPLXH6OMgHmdBp1uVd7R6exLwOfKzn0iOr5TSeAROL9kWzxqSIUx5oXKq0H_1frCbk6nR8ehAd7R_sPyTUG_l7B14MtsrlanrtHkJ2t4sfVlqDkw0Xvwd9zNU72 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VVCAuiH8CBRaJigOykqzXu94DQoE0ailEVtVKvbnOek1TuXZJUiFz4iF4Gh6HJ2HGdkyMBLeefNjJerwzuzPjfP4G4KVPFOs68RwvxlpVaCmcaIqJnPQGiaYukyIpUb4TuXskPhx7xxvwc_UtDMEqV2dieVDHuaF35D2ulKbsgsteUsMigtH47cUXhzpI0T-tq3YalYvs2-Irlm-LN3sjtPU25-Odw_e7Tt1hwDFC6SUx8VolE_RD4VvPSm5iX9qBlyT9yPUNhsdp7OlYKbyYyNWea2ItNI8TzFyivnFx3muwqagq6sDmu51JcNCUey4vW7UNMALio2tZwe5dV_d7s7PzBSdeG5f6Dq0FxL_DwlpcbGM214Lg-DbcqrNXNqzc7Q5s2OwuXK_6WRb34FuQp0XdWCctlpZ9IrifibAST-3i1_cfQxbMc_QsjJfssMSgs5FNCRpSsIo7neUJG57P8jia55ll9JqYYY7KgnxRA3kLEsFp0jz7bGN2gPfDSHwfjq5k6R9AJ0NFHgGzNvKEiQW3lKAm06m2KCgiodAE0vAuvF6tcGhq5nNqwJGGWAGRPcJ1e3Rhu5G-qBg__iH3iowV0kGAs5mo_p4BdSJKrXCoPCpuB1x1Yaslicts2sMrc4f1AbII_7h7F140w_RLAsVlNr8kGZ8yPE26PKy8o9HYlb4rlOx3QbX8phEgWvH2SDY7LenFqQLGuuvx_9V6Djdw_4Uf9yb7T-AmR3cvsez-FnSW80v7FFO15fRZvScYnFz1NvwNaldUiA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polyelectrolyte+Microcapsules%E2%80%94A+Promising+Target+Delivery+System+of+Amiodarone+with+the+Possibility+of+Prolonged+Release&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Kim%2C+Aleksandr+L&rft.au=Musin%2C+Egor+V&rft.au=Oripova%2C+Munojat+J&rft.au=Oshchepkova%2C+Yulia+I&rft.date=2023-02-08&rft.pub=MDPI+AG&rft.issn=1422-0067&rft.volume=24&rft.issue=4&rft_id=info:doi/10.3390%2Fijms24043348&rft.externalDocID=A751924127 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |